Trial Profile
Dose escalation of Ruxolitinib in patients with myelofibrosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Sep 2014
Price :
$35
*
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Myelofibrosis
- Focus Adverse reactions
- 09 Sep 2014 New trial record